📰 Process Performance Qualification News
Process Performance Qualification News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Process Performance Qualification. Real-time updates on events, politics, business and more.
November 15, 2023
15.11.2023 - Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system ...
August 13, 2023
Operator: Good morning, ladies and gentlemen and welcome to Adaptimmune’s Q2 Financial and Business Update Conference Call. I would now like to turn the meeting call over to Ms. Juli Miller.
August 8, 2023
Proceeds from $25 million registered direct offering in July allow initiation of pre-commercial launch activities for EB-101 Cash on hand plus proceeds from registered direct...
August 8, 2023
On track for Biologics License Application (BLA) submission in third quarter of 2023
June 9, 2023
CLEVELAND, June 09, 2023 -- Abeona Therapeutics Inc. today announced that it received feedback from the U.S. Food and Drug Administration on June 8, 2023, in which the Company gained the... | June 9, 2023
May 25, 2023
WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.
May 3, 2023
WuXi Vaccines offers a CDMO's perspective on meeting the global vaccine supply challenge.
March 26, 2023
Pfizer’s COVID-19 vaccine was the first shot approved by the US Food & Drug Administration (FDA) for Emergency Use, and Israel was the first country to mass vaccinate its population.
March 8, 2023
GenSight Biologics pushed back regulatory dates because of an operational issue at CDMO Brammer Bio, a subsidiary of Thermo Fisher.
March 7, 2023
PPQ campaign to start early May 2023 (previously end of March) with results expected in Q3 2023 EMA CHMP opinion now expected in Q1 2024 (previously September 2023) Regulatory News: GenSight